After a decade of service to OU, Dr. James M. Herman recently shared his intent to retire at the end of June.

University of Oklahoma researchers have discovered that some bacteria in the gut have their own unique “weapon system” to compete against other bacteria for dominance. Importantly, there is promising evidence that this system can be repurposed to target diseased cells like cancer.

Two researchers from the University of Oklahoma are partnering with Oklahoma start-up Xironetic to develop innovative methods for neurosurgical guidance, visualization and training.

The University of Oklahoma announced today Matthew Wade Hulver, Ph.D., will become the first universitywide vice president for research and partnerships, effective June 1, pending OU Board of Regents’ approval. This new role integrates the university’s research enterprise across campuses to accelerate growth and increase the university’s impact.

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to improve liver function.